Trial Outcomes & Findings for Message Framing for Telephone Quitline Callers (NCT NCT00589277)
NCT ID: NCT00589277
Last Updated: 2021-08-26
Results Overview
Percentage of those that self reported attempting to quit smoking at the 2 week follow up.
COMPLETED
PHASE1/PHASE2
2032 participants
2 week follow up
2021-08-26
Participant Flow
Participant milestones
| Measure |
Standard Care Counseling + Standard Care Print Information
Standard care counseling + standard care print information
|
Gain-Framed Counseling
Callers were randomly assigned to receive gain-framed counseling messages and received newly developed, exclusively gain-framed NYSSQL printed materials by mail.
|
|---|---|---|
|
Overall Study
STARTED
|
1222
|
810
|
|
Overall Study
Completed 2 Week Follow Up
|
603
|
424
|
|
Overall Study
Completed 3 Month Follow Up
|
762
|
524
|
|
Overall Study
COMPLETED
|
762
|
524
|
|
Overall Study
NOT COMPLETED
|
460
|
286
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Message Framing for Telephone Quitline Callers
Baseline characteristics by cohort
| Measure |
Standard Care Counseling
n=1222 Participants
Standard care counseling + standard care print information
|
Gain-Framed Counseling
n=810 Participants
Callers were randomly assigned to receive standard care counseling and materials or were exposed to gain-framed counseling statements and received newly developed, exclusively gain-framed NYSSQL printed materials by mail.
|
Total
n=2032 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
46.4 years
STANDARD_DEVIATION 13.9 • n=5 Participants
|
47.2 years
STANDARD_DEVIATION 13.4 • n=7 Participants
|
46.5 years
STANDARD_DEVIATION 13.7 • n=5 Participants
|
|
Sex: Female, Male
Female
|
675 Participants
n=5 Participants
|
478 Participants
n=7 Participants
|
1153 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
547 Participants
n=5 Participants
|
332 Participants
n=7 Participants
|
879 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2 week follow upPopulation: Per protocol
Percentage of those that self reported attempting to quit smoking at the 2 week follow up.
Outcome measures
| Measure |
Standard Care Counseling
n=603 Participants
Standard care counseling + standard care print information
|
Gain-Framed Counseling
n=424 Participants
Callers were randomly assigned to receive standard care counseling and materials or were exposed to gain-framed counseling statements and received newly developed, exclusively gain-framed NYSSQL printed materials by mail.
|
|---|---|---|
|
Quit Attempt
|
101 participants
|
132 participants
|
SECONDARY outcome
Timeframe: 2 week follow upPopulation: Per protocol
The number of survey respondents that had abstained from smoking at the 2 week follow up.
Outcome measures
| Measure |
Standard Care Counseling
n=603 Participants
Standard care counseling + standard care print information
|
Gain-Framed Counseling
n=424 Participants
Callers were randomly assigned to receive standard care counseling and materials or were exposed to gain-framed counseling statements and received newly developed, exclusively gain-framed NYSSQL printed materials by mail.
|
|---|---|---|
|
24 Hour Abstinence
|
76 participants
|
99 participants
|
SECONDARY outcome
Timeframe: 3 month follow upPopulation: Per protocol
The number of survey respondents that had abstained from smoking for 7 days at the 3 month follow up.
Outcome measures
| Measure |
Standard Care Counseling
n=762 Participants
Standard care counseling + standard care print information
|
Gain-Framed Counseling
n=524 Participants
Callers were randomly assigned to receive standard care counseling and materials or were exposed to gain-framed counseling statements and received newly developed, exclusively gain-framed NYSSQL printed materials by mail.
|
|---|---|---|
|
7 Day Abstinence
|
202 participants
|
148 participants
|
Adverse Events
Standard Care Counseling
Gain-Framed Counseling
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Benjamin Toll, Ph.D. Associate Professor of Psychiatry
Yale University School of Medicine
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place